Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RANKL_OPG

Financiado

Cerrado

The RANK Axis in Breast Cancer A comprehensive prospective evaluation of promis...

The RANK Axis in Breast Cancer A comprehensive prospective evaluation of promising novel biomarkers "Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer mortality in women worldwide. The recently identified Receptor Activator of Nuclear Factor (NF)-κB (RANK)-axis has stimulated novel research in... ver más

31/12/2016

GERMAN CANCER RESE...

169K€

Presupuesto del proyecto: 169K€

Líder del proyecto

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-12-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

GERMAN CANCER RESEARCH CENTE...

0.00€ | Lider

Proyectos interesantes

BREASTCANCERSTEM

Medical Technol...

Data Science

173K€ Cerrado

SAF2017-86117-R

Medical Technol...

Cancer Research

230K€ Cerrado

PATHSEC-BCA-BM

Medical Technol...

Data Science

100K€ Cerrado

BES-2012-051833

Medical Technol...

Cancer Research

43K€ Cerrado

p38Cure

Medical Technol...

Data Science

150K€ Cerrado

COGS

Medical Technol...

Data Science

17M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 169K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer mortality in women worldwide. The recently identified Receptor Activator of Nuclear Factor (NF)-κB (RANK)-axis has stimulated novel research in the field of breast cancer etiology, treatment, and prevention. Experimental data implicate RANK signalling in mammary tumor development. Preliminary human data show increased RANK expression correlated with poor outcome, and circulating concentrations of osteoprotegerin, the decoy RANK receptor inhibiting RANK-axis signalling, are increased in several conditions associated with decreased risk of breast cancer (e.g. pregnancy). The proposed research will provide the first evidence on the role of pre-diagnosis RANK-axis members in the etiology of breast cancer in the EPIC cohort, the largest prospective breast cancer case-control study worldwide, and in a complementary study in the unique Finnish Maternity Cohort. A RANK-inhibitor is clinically available and these studies have the potential to inform primary prevention trials. The research will be completed at the internationally recognized German Cancer Research Center (DKFZ). The fellow`s knowledge transfer objectives capitalize on almost a decade of research experience and established networks in U.S. pregnancy cohorts and Harvard University`s Nurses` Health Study. The fellow will: (1) Promote scientific exchange with U.S.-based cohorts and provide subject area expertise; (2) Broaden data analysis expertise at DKFZ to foster long-term collaborations among colleagues; and, (3) Lead and initiate cancer research projects and form strategic professional networks with European colleagues to develop ongoing collaborations. The novel research will strengthen DKFZ`s position as a center for innovative research in cancer epidemiology and the fellowship provides a unique opportunity to reinforce and expand collaborations between scientists at DKFZ and U.S. institutions."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores